Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 291
News
Gene Therapy Restores Hearing in Small Trial for Kids With Hereditary Deafness
Five out of six children with a type of hereditary hearing loss have shown improvement in their hearing and speech recognition after treatment with an experimental gene therapy. This is the first gene therapy trial for children with this type of hearing loss.
News
No Cervical Cancer Cases Following HPV Vaccination in Scotland
No cervical cancer cases have been observed in women who received the human papillomavirus (HPV) vaccine at age 12 or 13 in Scotland since the program began in 2008, according to a new study.
News
Experimental Insulin Pill Could Reduce Need for Injections
Researchers have developed an oral form of insulin that lowers glucose levels in animal models. The oral insulin, encased in a nano-carrier that delivers insulin to the liver, is expected to begin human trials in 2025.
News
Could Chicken Eggs Be a Low-Cost Option for Cancer Studies?
Researchers from King’s College London (KCL) suggest that fertilized chicken eggs could provide a low-cost option for cancer imaging studies, potentially helping to resolve some ethical and economic issues.
News
Energy-Starved Breast Cancer Cells Scavenge From Their Surroundings
Breast cancer cells can consume their surroundings to overcome starvation and continue cell growth, according to a new study, which describes a previously unknown method of cancer cell survival.
News
2023 Saw Second-Highest Number of Drug Approvals in 30 Years
The US FDA approved 55 novel drugs in 2023 – the second-highest figure in the last 30 years. This is almost a 50% increase compared to 2022, which saw 37 new approvals.
News
Online-Purchased Tejocote Supplements May Contain Poisonous Plant
The FDA has issued a new warning after the analysis of 10 online-purchased tejocote supplements – promoted by some on social media for weight loss – revealed that 9 instead contained yellow oleander, a highly toxic plant.
News
Weight Loss Drugs Not Associated With Increased Suicidal Thoughts, Study Finds
A new study suggests that diabetes and weight loss drugs containing semaglutide are not associated with an increase in suicidal thoughts. Reports prompted a review of the possibility they could increase risks of suicidal thoughts and self-injury.
News
Antibody Shot Could Cut Infant RSV Hospitalizations by 80%
The preventative antibody shot niresvimab protects against hospitalization of infants infected with respiratory syncytial virus (RSV), according to results from a new clinical trial.
News
B12 Deficiency and Multiple Sclerosis Share Intriguing Similarities
A novel molecular link between vitamin B12 and MS in astrocytes – important non-neuronal brain cells – has been unearthed in a new study. The research suggests that brain-targeted B12 formulations may support MS treatment.
Advertisement
